Medicine
Mepsevii 10 mg/5 mL injection
Mepsevii 10 mg/5 mL injection is a prescription medicine containing Vestronidase alfa for intravenous use, marketed by Ultragenyx Pharmaceutical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store under refrigeration at 2°C to 8°C (36°F to 46°F). Do not freeze or…
Key facts
- Active ingredient (INN)
- Vestronidase alfa
- Brand
- Mepsevii
- Strength
- 10 mg/5 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 5 mL
- Marketing authorisation holder
- Ultragenyx Pharmaceutical
- Manufacturer
- Ultragenyx Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- Store under refrigeration at 2°C to 8°C (36°F to 46°F). Do not freeze or shake. Protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A16AB18 Vestronidase alfa
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 November 2017
- Identifiers
- DailyMed set ID 925d4e21-fd98-474d-a34d-a0b3558ed750NDC 69794-001Application BLA761047
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-use in 1 carton / 5 mL in 1 vial, single-use | 69794-001-01 | Ultragenyx Pharmaceutical | 15 November 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Vestronidase alfa is a lysosomal beta glucuronidase indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII (MPS VII, Sly syndrome). It is available as injection for intravenous use. MedsAcross supplies Vestronidase alfa for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Vestronidase alfaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- MEPSEVII prescribing information (Ultragenyx Pharmaceutical) · U.S. National Library of Medicine, DailyMed
- Mepsevii: European public assessment report (EPAR) · European Medicines Agency
Need Mepsevii 10 mg/5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.